Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment Article

Full Text via DOI: 10.1111/tid.12197 PMID: 24628809 Web of Science: 000333969500011

Cited authors

  • Schieffelin, J. S.; Garcia-Diaz, J. B.; Loss, G. E., Jr.; Beckman, E. N.; Keller, R. A.; Staffeld-Coit, C.; Garces, J. C.; Pankey, G. A.


  • BackgroundDematiaceous, or dark-pigmented, fungi are known to cause infections such as phaeohyphomycosis, chromoblastomycosis, and mycetoma. These fungi are becoming increasingly important opportunistic pathogens in solid organ transplant recipients (SOTR). We present a retrospective chart review of 27 SOTR who developed phaeohyphomycosis infections post transplant from 1988 to 2009.; MethodsCases were reviewed for fungal species isolated, date and source of culture, immunosuppressive and fungal therapy used, and outcome. The majority of isolates obtained were from the skin and soft tissue, with 3 pulmonary and brain abscesses.; ResultsThe time from transplantation to onset of infection ranged from 2months to 11years. The species isolated were Exophiala (11), Ochroconis (3), Alternaria (2), Phoma (2), Wangiella (1), Cladosporium (1), Aureobasidium (1), Chaetomium (1), Coniothyrium (1), and non-sporulating fungi (2). An additional 4 patients had infections confirmed by pathology, but no cultures were done. Most of the affected skin lesions were surgically debrided and treated with itraconazole; 2 patients were treated with voriconazole and 2 with amphotericin D. Death from fungal disease occurred only in patients with pulmonary and brain abscesses.; ConclusionsAs the number of SOTR increases, so does the incidence of fungal infections in that population. Surgery, along with antifungal therapy and a reduction in immunosuppression, are the cornerstones of treatment.

Publication date

  • 2014

Published in

International Standard Serial Number (ISSN)

  • 1398-2273

Start page

  • 270

End page

  • 278


  • 16


  • 2